|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||
| Condition | Onset Date / Period | Status |
|---|---|---|
| Recurrent urinary tract infection | 19-Dec-2024 | active |
| Asthma | 20-Dec-2016 | active |
| Acute viral pharyngitis | 28-Jun-2025 - 06-Jul-2025 | inactive |
| Acute infective cystitis | 19-Dec-2024 - 20-Dec-2024 | inactive |
| Acute infective cystitis | 17-Aug-2024 - 21-Aug-2024 | inactive |
| Acute bronchitis | 31-Jan-2024 - 07-Feb-2024 | inactive |
| Viral sinusitis | 15-Dec-2018 - 28-Dec-2018 | inactive |
| Viral sinusitis | 06-Feb-2016 - 13-Feb-2016 | inactive |
| Acute viral pharyngitis | 08-Sep-2015 - 15-Sep-2015 | inactive |
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| NDA020983 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Ventolin] | 2025-07-05 | - | 2 actuations (0.18 mg) every 4 to 6 hours as needed | Asthma |
| Fluticasone propionate 50 microgram/actuation nasal spray | 2025-07-05 | - | 2 sprays in each nostril once daily | Asthma |
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 15-Feb-2025 |
| SARS-CoV-2 mRNA vaccine | 22-May-2021 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 23-Jan-2021 |
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 08-Dec-2018 | - |
| Medication reconciliation | 08-Dec-2018 | - |
| Assessment of health and social care needs | 08-Dec-2018 | - |
| Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) | 08-Dec-2018 | - |
| Assessment of substance use | 08-Dec-2018 | - |
| No known allergies or intolerances |
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Asthma self management | 20-Dec-2016 | Asthma (disorder) |
|
| Vital Signs | 2025-07-05 | 2025-06-28 |
|---|---|---|
| Body Height | 179.6 cm | - |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 1 {score} | - |
| Body Weight | 92.4 kg | - |
| Body mass index (BMI) [Ratio] | 28.7 kg/m2 | - |
| Heart rate | 64 /min | - |
| Respiratory rate | 15 /min | - |
| Blood pressure panel with all children optional | 85 mm[Hg] | - |
| Body temperature | - | 37.6 Cel |
| Recent Lab Observations | 19-DEC-2024 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Urine by Test strip | 2.1 | 0 - 5 | mg/dL |
| Ketones [Presence] in Urine by Test strip | Urine ketone test negative | ||
| Specific gravity of Urine by Test strip | 1.0 L | 1.005 - 1.030 | {nominal} |
| pH of Urine by Test strip | 7.0 | 4.5 - 8.0 | pH |
| Protein [Mass/volume] in Urine by Test strip | 12.6 | 0 - 20 | mg/dL |
| Nitrite [Presence] in Urine by Test strip | Urine nitrite positive | ||
| Hemoglobin [Presence] in Urine by Test strip | Urine blood test = + | ||
| Leukocyte esterase [Presence] in Urine by Test strip | Urine leukocyte test | ||
| Leukocytes [#/area] in Urine sediment by Microscopy high power field | 11.8 | 0 - 15 | /[HPF] |
| Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 1.0 | 0 - 5 | /[HPF] |
| Epithelial cells [#/area] in Urine sediment by Microscopy high power field | 3.9 | 0 - 10 | /[HPF] |
| Casts [Presence] in Urine sediment by Light microscopy | Urine microscopy: no casts | ||
| Mucus [Presence] in Urine sediment by Light microscopy | Mucus in urine | ||
| Bacteria [#/area] in Urine sediment by Microscopy high power field | Finding of presence of bacteria | ||
| Bacteria identified in Urine by Culture |
| No known devices |